Key diagnostic steps in aortic stenosis (AS) echocardiography

  • With an average survival rate of 50% at two years and 20% at five years, the timely and accurate diagnosis of AS is essential1
  • An integrated and stepwise approach to echocardiography assessment of AS is a key diagnostic tool for confirming the diagnosis and severity of AS2
  • However, it is important to understand the limitations of echocardiography to avoid the underestimation of AS severity3,5

Optimising assessments with echocardiography

  • Echocardiography is a key diagnostic tool for:2
    • Confirming the diagnosis and severity of AS
    • Assessing valve calcification, left-ventricle (LV) function and wall thickness
    • Detecting other valve disease or aortic pathology
    • Providing prognostic information
  • Current international recommendations for the echocardiographic evaluation of patients with AS rely upon measurement of mean pressure gradient (the most robust parameter), peak transvalvular velocity (Vmax) and valve area2
  • Both the EACVI and ESC/EACTS VHD guidelines recommend a stepwise approach to assessing AS severity using echocardiography:2,5

* High flow may be reversible in patients with anaemia, hyperthyroidism or arterio-venous fistulae, and may also be present in patients with hypertrophic obstructive cardiomyopathy. Upper limit of normal flow using pulsed Doppler echocardiography: cardiac index 4.1 L/min/m2 in men and women, stroke volume index (SVi) 54 mL/m2 in men, 51 mL/m2 in women)
Consider also: typical symptoms (with no other explanation), LV hypertrophy (in the absence of coexistent hypertension) or reduced LV longitudinal function (with no other cause).
DSE flow reserve= >20% increase in stroke volume in response to low-dose dobutamine.
§ Pseudo-severe aortic stenosis= AVA >1.0 cm2 with increased flow.
Thresholds for severe aortic stenosis assessed by means of CT measurement of aortic valve calcification (Agatston units): men >3000, women >1600= highly likely; men >2000, women >1200= likely; men <1600, women <800= unlikely.

Check our latest articles

View all articles

Stay informed with our newsletter

By providing your personal information, you agree to allow Edwards Lifesciences and its agents to use this information to communicate with you in the future, including information about services, events, and programs. Edwards Lifesciences and its agents will not sell, rent, or otherwise distribute your name and any personally identifiable information outside of Edwards Lifesciences and its agents, Edwards Lifesciences will use your information in accordance with the Edwards privacy policy.

Our monthly updates provide you the latest developments in TAVI and aortic stenosis.Read more

AS, aortic stenosis; AVA, aortic valve area; AVR, aortic valve replacement; EACVI, European society of cardiovascular imaging; EACTS, European association for cadio-thoracic surgery; ESC, European society of cardiology; LV, left ventricle; LVEF, left ventricular ejection fraction; Pm, mean pressure gradient; sAS, severe aortic stenosis; Vmax, peak jet velocity.

* Adverse features according to clinical, imaging (echocardiography or CT scanning) and/or assessment of biomarkers.6
† A positive result following exercise testing is the development of symptoms or a sustained blood pressure fall below the patient’s baseline.6


1 Otto CM. Heart 2000;84:211–218.
2 Raddatz MA, et al. Open Heart 2020;7:e001331.
3 Delgado V, et al. J Am Coll Cardiol Img. 2019;12:267–282.
4 Baumgartner H, et al. Eur Heart J Cardiovasc Imaging 2017;18(3):254-275.
5  Vahanian A, et al. Eur Heart J. 2021; ehab395.doi:10.1093/eurheartj/ ehab395.

Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult where applicable).

PP--EU-4331 v2.0